ITPA and tuberculosis: Above, I have outlined examples where ITPA polymorphism/mutation is detrimental to patient outcomes (thiopurine toxicity/infantile death) and examples indicating that ITPA polymorphism is beneficial to patient outcomes (reduced anemia in hepatitis C patients, young-onset TB).